Lyme disease vaccine: 1st potential shot in 20 years enters late-stage trial
The only prior Lyme vaccine for people, made by another company, was pulled off the U.S. market in 2002.
Stay updated with breaking news from Robert Terwilliger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The only prior Lyme vaccine for people, made by another company, was pulled off the U.S. market in 2002.
It would be the first major vaccine of its type in 20 years. The companies are seeking thousands of volunteers in the U.S. and Europe as cases keep rising.
A new Lyme disease vaccine developed by Pfizer and Valneva is being tested in late-stage clinical trials. There hasn't been a Lyme disease vaccine available in the United States since 2002, when Lymetrix was pulled off the market due to low demand. Case rates have skyrocketed since the early 1990s. Pennsylvania sees more cases than any other state.
Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years -- in hopes of better fighting the tick-borne threat.
Amplifying Atlanta